Ghadjar, Pirus (2011). Letter to the Editor on: A. Siegmann et al. Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival. Results of a retrospective study. In: Strahlenther Onkol 2011;187:467-72 (No. 8) (DOI 10.1007/s00066-011-2229-3). P. Ghadjar, D. Zwahlen, D.M. Aebersold: Selection bias is not a good reason for dose intensification in patients with PSA recurrence after radical prostatectomy. Strahlentherapie und Onkologie, 187(11), 763; author reply 764. Heidelberg: Urban and Vogel 10.1007/s00066-011-9229-1
|
Text
66_2011_Article_9229.pdf - Published Version Available under License Publisher holds Copyright. Download (95kB) | Preview |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology |
UniBE Contributor: |
Ghadjar, Pirus |
ISSN: |
0179-7158 |
Publisher: |
Urban and Vogel |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:19 |
Last Modified: |
05 Dec 2022 14:05 |
Publisher DOI: |
10.1007/s00066-011-9229-1 |
PubMed ID: |
22037657 |
Web of Science ID: |
000296533000009 |
BORIS DOI: |
10.7892/boris.6258 |
URI: |
https://boris.unibe.ch/id/eprint/6258 (FactScience: 211168) |
Actions (login required)
 |
Edit item |